购物车
- 全部删除
- 您的购物车当前为空
NSC 12是一种口服活性的泛-FGF陷阱,能抑制FGF依赖性肿瘤细胞的增殖、血管生成和转移。NSC 12可结合FGF2并干扰其与FGFR1的相互作用,但不影响FGF2结合肝素或硫酸肝素蛋白多糖(HSPGs)的能力,具有潜在的抗肿瘤活性。NSC 12还阻止其他几种FGF亚型形成HSPG/FGF/FGFR三元复合物。
NSC 12是一种口服活性的泛-FGF陷阱,能抑制FGF依赖性肿瘤细胞的增殖、血管生成和转移。NSC 12可结合FGF2并干扰其与FGFR1的相互作用,但不影响FGF2结合肝素或硫酸肝素蛋白多糖(HSPGs)的能力,具有潜在的抗肿瘤活性。NSC 12还阻止其他几种FGF亚型形成HSPG/FGF/FGFR三元复合物。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 412 | 现货 | |
5 mg | ¥ 993 | 现货 | |
10 mg | ¥ 1,650 | 现货 |
产品描述 | NSC 12 is an orally active pan-FGF trap that inhibits FGF-dependent tumor cell proliferation, angiogenesis, and metastasis.NSC 12 binds FGF2 and interferes with its interaction with FGFR1, but does not affect the ability of FGF2 to bind heparin or heparan sulfate proteoglycans (HSPGs), with potential antitumor activity.NSC 12 also organizes several other FGF isoforms to form the HSPG/FGF/FGFR ternary complex. |
别名 | NSC12 |
分子量 | 484.52 |
分子式 | C24H34F6O3 |
CAS No. | 102586-30-1 |
Smiles | C[C@@]12[C@]([C@]3([C@@]([C@]4(C)C(=CC3)C[C@@H](O)CC4)(CC1)[H])[H])(CC[C@@]2([C@H](CC(C(F)(F)F)(C(F)(F)F)O)O)[H])[H] |
密度 | 1.31 g/cm3 (Predicted) |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度信息 | Ethanol:PBS (pH 7.2)(1:2): 0.33 mg/mL (0.68 mM), < 0.1 mg/mL (insoluble) DMSO: 8 mg/mL (16.51 mM), Sonication is recommended. Ethanol: 8 mg/mL (16.51 mM), Sonication is recommended. DMF: 8 mg/mL (16.51 mM), Sonication is recommended. |
评论内容